These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6982717)

  • 1. Prolonged lifespans in female NZB/NZW mice treated with the experimental immunoregulatory drug frentizole.
    Walker SE; Solsky M; Schnitzer B
    Arthritis Rheum; 1982 Nov; 25(11):1291-7. PubMed ID: 6982717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frentizole therapy of active systemic lupus erythematosus.
    Kay DR; Valentine TV; Walker SE; Valentine MH; Bole GG
    Arthritis Rheum; 1980 Dec; 23(12):1381-7. PubMed ID: 7006613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frentizole therapy in systemic lupus erythematosus.
    Sabharwal UK; Vaughan JH; Kaplan RA; Robinson CA; Curd JG
    Arthritis Rheum; 1980 Dec; 23(12):1376-80. PubMed ID: 7006612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of neoplasms in female NZB/NZW mice treated with pulse doses of cyclophosphamide.
    Walker SE; Anver MR
    Vet Immunol Immunopathol; 1983 Nov; 5(1):97-104. PubMed ID: 6606891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to therapy in mature Palmerston North mice treated with cyclophosphamide or hydrocortisone sodium succinate.
    Walker SE; Schnitzer B
    Arthritis Rheum; 1980 May; 23(5):539-44. PubMed ID: 6966498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus.
    Zoja C; Casiraghi F; Conti S; Corna D; Rottoli D; Cavinato RA; Remuzzi G; Benigni A
    Arthritis Rheum; 2007 May; 56(5):1629-37. PubMed ID: 17469145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated appearance of neoplasms in female NZB/NZW mice treated with high-dose cyclophosphamide.
    Walker SE; Anver MR
    Arthritis Rheum; 1979 Dec; 22(12):1338-43. PubMed ID: 391238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.
    Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S
    J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frentizole in systemic lupus erythematosus. Current status.
    Bang NU
    Arthritis Rheum; 1980 Dec; 23(12):1388-90. PubMed ID: 7006614
    [No Abstract]   [Full Text] [Related]  

  • 13. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
    Hughes GC; Martin D; Zhang K; Hudkins KL; Alpers CE; Clark EA; Elkon KB
    Arthritis Rheum; 2009 Jun; 60(6):1775-84. PubMed ID: 19479860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.
    Szalai AJ; Weaver CT; McCrory MA; van Ginkel FW; Reiman RM; Kearney JF; Marion TN; Volanakis JE
    Arthritis Rheum; 2003 Jun; 48(6):1602-11. PubMed ID: 12794828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
    Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged lifespan and high incidence of neoplasms in NZB/NZW mice treated with hydrocortisone sodium succinate.
    Walker SE; Anver MR; Schechter SL; Bole GG
    Kidney Int; 1978 Aug; 14(2):151-7. PubMed ID: 691974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frentizole therapy of thrombocytopenia in systemic lupus erythematosus and refractory idiopathic thrombocytopenic purpura.
    O'Duffy JD; Colgan JP; Phyliky RL; Ferguson RH
    Mayo Clin Proc; 1980 Oct; 55(10):601-5. PubMed ID: 7191033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
    Atencio S; Amano H; Izui S; Kotzin BL
    J Immunol; 2004 Apr; 172(7):4159-66. PubMed ID: 15034028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.